ACC: Esperion’s Nexletol busts cholesterol levels regardless of statin, ezitimibe therapy

Esperion notched major back-to-back FDA wins in February with its cholesterol-busting duo Nexlitol and Nexlizet. Now, with physicians largely unfamiliar with the drugs, the company is hoping new clinical data will help build confidence as both prepare to hit the market. 

In multiple phase 3 trials, Esperion’s Nexletol significantly lowered levels of high-sensitivity C-reactive protein in patients with abnormally high triglyceride levels whether they were actively taking standard-of-care statins or not, according to a pooled data analysis presented Saturday at the American College of Cardiology scientific sessions. 

In patients whose protein levels measured above a baseline marker––a sign of inflammation––Nexletol lowered those levels by 42% at 12 weeks, Esperion said in a release. Nexletol significantly cut those levels whether or not patients were taking statins and regardless of the intensity of statins they received.


Veeva 2020 Unified Clinical Operations Survey

We believe you have the knowledge and expertise to make this year’s Veeva 2020 Clinical Operations Report even more robust and insightful than the last. Please take a moment to share your opinion in this 10-minute survey. All qualified respondents will be entered to win a $500 Amazon gift card.

In a separate analysis, Nexletol significantly lowered levels of LDL-C and other lipids regardless of whether patients were treated with a drug alongside cholesterol buster ezitimibe.

The new analyses may help prescribers grow more comfortable with soon-to-hit-the-market Nexletol, a cholesterol fighter that nabbed an FDA approval in late February to lower LDL-C levels in patients with abnormally high cholesterol levels or an established CV disease who had reached maximum statin tolerance. The drug is expected to start distribution March 30.

RELATED: Esperion scores FDA nod for cholesterol-buster Nexletol 

Source link

100% Pure Vitamin C Powder Ascorbic Acid Immune Support Kosher Vegan Supplement

Here’s How Coronavirus Tests Work–and Who Offers Them